The Immediate Effects of Kinesio-Taping on Scapular Muscle Endurance and Strength in Asymptomatic Subjects

April 10, 2020 updated by: Zeynep Hazar Kanik, Gazi University

The Immediate Effects of Kinesio-Taping on Scapular Muscle Endurance and Strength in Asymptomatic Subjects: A Single-Blind, Randomized, Placebo-Controlled Study

The purpose of this study was to investigate the immediate effects of Kinesio-taping (KT) on scapular muscle endurance and strength and compared to placebo Kinesio-taping in asymptomatic subjects.

Study Overview

Detailed Description

Thirty-nine asymptomatic subjects (20 females and 19 males, mean age 20.46±1.09 years, mean BMI 21.99±3.02 kg/m2) were included in this study. Subjects were randomly allocated to KT (with the muscle facilitation technique) and placebo-KT (without any technique and tension). Scapular isometric muscle endurance was measured with a scapular muscle endurance test. The strength of the upper, middle, and lower trapezius, and serratus anterior was assessed using a hand-held digital dynamometer. Data were analyzed with 2x2 [groups (KT and Placebo-KT) x time (pre- and post-intervention)] mixed-model ANOVA.

Study Type

Interventional

Enrollment (Actual)

39

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Yenimahalle
      • Ankara, Yenimahalle, Turkey, 06500
        • Gazi University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 25 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • An age range of 18 to 25 years,
  • The ability to participate voluntarily.

Exclusion Criteria:

  • Shoulder injuries in the last year, previous shoulder surgery, shoulder dislocation, and having performed upper-body exercises within the 24 hours before each evaluation session. - Diagnosed with cardiovascular or neurological disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Kinesio-taping (KT)
The skin will first be properly cleaned with rubbing alcohol. An I-shaped strip of Kinesio tape with a 5-cm width was applied over the middle trapezius from origin to insertion in the KT group. Kinesio-tape size was measured from the T3 spinal process to the acromion, while the subject is in sitting position relaxed with the arm at the trunk side. The subject was then instructed to move the arm into horizontal adduction and neck flexion. At this position, the tape was applied involving the middle trapezius, ending on the acromion, with 50% tension as recommended for this technique.
The resistance of the trapezius and serratus anterior muscles to fatigue was assessed using the scapular muscle endurance test.
Upper trapezius (UT), middle trapezius (MT), lower trapezius (LT), and serratus anterior (SA) muscle strengths were tested using a hand-held digital dynamometer (Lafayette Manual Muscle Tester, Model 01165).
Placebo Comparator: Placebo Kinesio-taping (KT)
Kinesio-tape was applied with no tension and technique on the middle trapezius.
The resistance of the trapezius and serratus anterior muscles to fatigue was assessed using the scapular muscle endurance test.
Upper trapezius (UT), middle trapezius (MT), lower trapezius (LT), and serratus anterior (SA) muscle strengths were tested using a hand-held digital dynamometer (Lafayette Manual Muscle Tester, Model 01165).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Scapular endurance test
Time Frame: 1 day
The resistance of the trapezius and serratus anterior muscles to fatigue was assessed using the scapular muscle endurance test. Subjects were in standing position with their shoulders and elbows flexed to 90°, and they were instructed to hold a dynamometer between their hands. The scapula was placed in a neutral position, and an adjustable spacer was set between their elbows to maintain the test position. Then, the subjects were asked to externally rotate the shoulders to attain a 1-kg load and to maintain this force, which was displayed on the dynamometer. The test was terminated when the subjects were unable to maintain the resistance and dropped the adjustable spacer, failed to maintain the 90° shoulder flexion, or reported an unbearable discomfort. The test was carried out twice and the average result recorded in seconds.
1 day
Muscle strength test
Time Frame: 1 day
Upper trapezius (UT), middle trapezius (MT), lower trapezius (LT), and serratus anterior (SA) muscle strengths were tested using a hand-held digital dynamometer (Lafayette Manual Muscle Tester, Model 01165). Strength of these muscles was assessed with the "break test method," in which the subject resisted the prescribed motion until the examiner overcame the subject's isometric contraction. Test position of trapezius and serratus anterior muscles was described by Ekstrom et al. Following a familiarization test, subjects performed two trials with standardized verbal encouragement, and the average value of the 2 trials was used for statistical analysis.
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Chair: Zeynep HAZAR KANIK, PhD, PT, Gazi University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2018

Primary Completion (Actual)

November 15, 2018

Study Completion (Actual)

August 15, 2019

Study Registration Dates

First Submitted

April 10, 2020

First Submitted That Met QC Criteria

April 10, 2020

First Posted (Actual)

April 14, 2020

Study Record Updates

Last Update Posted (Actual)

April 14, 2020

Last Update Submitted That Met QC Criteria

April 10, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 25901600-537

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Asymptomatic Subjects

Clinical Trials on -Scapular endurance test

3
Subscribe